Treasury Wine Estates (ASX:TWE), the global producer behind premium brands like Penfolds and Wolf Blass, saw its shares tumble to a decade low on Monday after the company scrapped its fiscal 2026 earnings forecast. The wine giant attributed the move to slowing demand in China and ongoing challenges in its U.S. operations.
The Sydney-listed stock plunged as much as 14.2% to A$5.99, marking its lowest point since September 2015. The drop came after Treasury Wine announced it no longer viewed its previous “low to mid double-digit” earnings growth projection for fiscal 2026 as realistic.
According to preliminary figures, sales of the company’s flagship Penfolds brand in China underperformed expectations despite modest improvement in September. Weaker consumer demand persisted through the Mid-Autumn Festival period, a traditionally strong sales window for luxury wines. The disappointing figures highlight the continued volatility in China’s premium wine market following recent economic headwinds.
In the United States, Treasury Americas also struggled due to a distributor transition in California. The company is currently negotiating a settlement with former distributor Republic National Distribution Company, with unresolved issues around inventory treatment potentially weighing further on shipments and revenue in the current fiscal year.
Adding to investor unease, Treasury Wine Estates announced a pause on its A$200 million share buyback program, pending greater visibility on trading conditions and global demand trends.
The setback underscores the mounting pressure facing international wine producers amid shifting global consumption patterns and economic uncertainty. Analysts suggest Treasury Wine may need to recalibrate its growth strategy as it navigates slower recovery in China and operational challenges in the U.S., its two largest export markets.


Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 



